Carcinoma, Hepatocellular
"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
MeSH Number(s)
C04.557.470.200.025.255
C04.588.274.623.160
C06.301.623.160
C06.552.697.160
Concept/Terms
Carcinoma, Hepatocellular- Carcinoma, Hepatocellular
- Carcinomas, Hepatocellular
- Hepatocellular Carcinomas
- Hepatocellular Cancer
- Cancer, Hepatocellular
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Liver Cancer, Adult
- Adult Liver Cancer
- Adult Liver Cancers
- Cancer, Adult Liver
- Cancers, Adult Liver
- Liver Cancers, Adult
- Liver Cell Carcinoma, Adult
- Hepatocellular Carcinoma
- Hepatoma
- Hepatomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".
This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 9 | 14 |
1995 | 8 | 9 | 17 |
1996 | 9 | 8 | 17 |
1997 | 7 | 3 | 10 |
1998 | 11 | 3 | 14 |
1999 | 15 | 4 | 19 |
2000 | 17 | 6 | 23 |
2001 | 15 | 6 | 21 |
2002 | 24 | 3 | 27 |
2003 | 12 | 7 | 19 |
2004 | 9 | 10 | 19 |
2005 | 13 | 8 | 21 |
2006 | 15 | 7 | 22 |
2007 | 8 | 10 | 18 |
2008 | 26 | 9 | 35 |
2009 | 26 | 7 | 33 |
2010 | 26 | 7 | 33 |
2011 | 36 | 8 | 44 |
2012 | 38 | 9 | 47 |
2013 | 55 | 12 | 67 |
2014 | 57 | 5 | 62 |
2015 | 49 | 6 | 55 |
2016 | 50 | 4 | 54 |
2017 | 60 | 7 | 67 |
2018 | 73 | 5 | 78 |
2019 | 77 | 7 | 84 |
2020 | 78 | 10 | 88 |
2021 | 86 | 7 | 93 |
2022 | 69 | 3 | 72 |
2023 | 61 | 0 | 61 |
2024 | 13 | 1 | 14 |
Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.
-
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Sci Adv. 2024 Apr 05; 10(14):eadj7540.
-
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial. JAMA. 2024 03 19; 331(11):920-929.
-
Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study. Eur Radiol Exp. 2024 Mar 12; 8(1):29.
-
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Res Commun. 2024 03 07; 4(3):682-690.
-
Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry. Radiol Imaging Cancer. 2024 Mar; 6(2):e230056.
-
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules. 2024 Feb 26; 14(3).
-
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb; 18(1-3):113-119.
-
Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency. J Pathol. 2024 05; 263(1):32-46.
-
Human-scale navigation of magnetic microrobots in hepatic arteries. Sci Robot. 2024 Feb 14; 9(87):eadh8702.
-
[90Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to "TheraSphere" for Cost-Effective Treatment of Liver Cancer. Cancer Biother Radiopharm. 2024 Feb; 39(1):82-91.